Driving Value in Healthcare: Perspectives from Two ACO Executives
A firm understanding of the key components and drivers of healthcare reform is increasingly important within the pharmaceutical, biotech, and medical device industries. Manufacturers are typically not identified as one of the key stakeholders (Payers, Providers and Patients) within healthcare reform, yet play a critical role in improving the health of patients as they strive to identify and bring new and innovative products to the market. In this two-part paper, we explore the evolving role of accountable care organizations (ACOs) as a core element of the Affordable Care Act and healthcare reimbursement redesign.
